V030-5179 Screening compound: 4-benzoyl-8-(3-methylbenzoyl)-3-(4-methylpiperazine-1-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane

V030-5179 Screening compound: 4-benzoyl-8-(3-methylbenzoyl)-3-(4-methylpiperazine-1-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane
V030-5179 Screening compound: 4-benzoyl-8-(3-methylbenzoyl)-3-(4-methylpiperazine-1-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane alternative view

Chemical Structure Depiction of ChemDiv screening compound V030-5179
4-benzoyl-8-(3-methylbenzoyl)-3-(4-methylpiperazine-1-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V030-5179

Molecular Formula

C28H34N4O4 (C28 H34 N4 O4)

Compound Name

4-benzoyl-8-(3-methylbenzoyl)-3-(4-methylpiperazine-1-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane

IUPAC name

4-benzoyl-8-(3-methylbenzoyl)-3-(4-methylpiperazine-1-carbonyl)-1-oxa-48-diazaspiro[4.5]decane

SMILES

Cc1cccc(C(N(CC2)CCC22OCC(C(N3CCN(C)CC3)=O)N2C(c2ccccc2)=O)=O)c1

InChI

InChI=1S/C28H34N4O4/c1-21-7-6-10-23(19-21)25(33)30-13-11-28(12-14-30)32(26(34)22-8-4-3-5-9-22)24(20-36-28)27(35)31-17-15-29(2)16-18-31/h3-10,19,24H,11-18,20H2,1-2H3/t24-/m1/s1

InChI Key

YZZMBDCPSFDSPY-XMMPIXPASA-N

MDL Number (MFCD)

MFCD19774197

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

490.6

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.472

Distribution Coefficient, logD

1.278

Water Solubility, LogSw

-1.80

Polar Surface Area

59.707

Acid Dissociation Constant (pKa)

20.29

Base Dissociation Constant (pKb)

7.15

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

46.43

V030-5179 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

CNS BBB Library (22607 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V030-5179 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V030-5179?
Check Price and Availability of V030-5179, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V030-5179 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V030-5179
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V030-5179
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V030-5179 available by request